Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium aescinate tablets for postoperative hemorrhoid edema
ChiCTR2000039208Phase 4Recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Oct 2019
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of escin in postoperative edema, postoperative pain and postoperative hemorrhage (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Proportion of patients without edema on postoperative day 7. Started Oct 2019; status: recruiting.
02
Drugs
escin
03
Conditions
postoperative edemapostoperative painpostoperative hemorrhage
Beyond the preview
Go deeper on ChiCTR2000039208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039208.